Cargando...
Trials in type 1 diabetes: Antigen-specific therapies
Type 1 diabetes (T1D) results from an aberrant immunological response against the insulin-producing beta cells in the islets of the pancreas. The ideal therapy would restore immune balance in a safe and lasting fashion, stopping the process of beta cell decay. The efficacy of immune suppressive agen...
Guardado en:
| Publicado en: | Clin Immunol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5777514/ https://ncbi.nlm.nih.gov/pubmed/23490422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2013.02.002 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|